Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination (Q40513340)

21 September 2017

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination (English)

1 reference

21 September 2017

2

1 reference

21 September 2017

5

1 reference

21 September 2017

Robert A Vierkant

3

0 references

Gregory A. Poland

series ordinal

6

object named as

Gregory A Poland

1 reference

21 September 2017

1

Inna G Ovsyannikova

1 reference

21 September 2017

V Shane Pankratz

4

1 reference

PubMed ID

15121303

21 September 2017

language of work or name

English

0 references

publication date

1 May 2004

1 reference

21 September 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

21 September 2017

22

1 reference

21 September 2017

1914-1920

1 reference

21 September 2017

15-16

1 reference

Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Measles elimination: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Failure to reach the goal of measles elimination. Apparent paradox of measles infections in immunized persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Measles reimmunization in children seronegative after initial immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The genetic basis for variation in antibody response to vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Twin studies of immunogenicity--determining the genetic contribution to vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Structural basis of T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The role of mass spectrometry in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Immunogenetic mechanisms of antibody response to measles vaccine: the role of the HLA genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

The association of class I HLA alleles and antibody levels after a single dose of measles vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Identification of an association between HLA class II alleles and low antibody levels after measles immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Associations between Human Leukocyte Antigen Homozygosity and Antibody Levels to Measles Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Relationship of HLA-DQAI alleles and humoral antibody following measles vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

A recovered avian myelocytomatosis virus that induces lymphomas in chickens: pathogenic properties and their molecular basis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Frequency of HLA-DPB1 disparities detected by reference strand-mediated conformation analysis in HLA-A, -B, and -DRB1 matched siblings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

Enzyme-linked immunosorbent assay for detection of measles antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.11.016

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.11.016

1 reference

21 September 2017

1 reference

PubMed ID

15121303